Missouri House Bill HB2309

Missouri 2026 Regular Session

• Introduced: 1/7/26
• Refer: 1/8/26
• Report Pass: 2/19/26
• Refer: 2/25/26

Caption

Establishes the "End Organ Harvesting Act of 2026"

Impact

The proposed changes in HB 2309 is significant as it directly impacts how insurance companies in Missouri will manage coverage for certain organ transplants. By enacting this legislation, the state would safeguard its residents against potential exploitation in international organ trade practices that could compromise ethical medical standards. The bill aligns Missouri's regulatory framework with global human rights concerns related to organ donation and transplantation, potentially cultivating a more ethically-driven healthcare environment for residents considering organ transplants.

Summary

House Bill 2309, referred to as the 'End Organ Harvesting Act of 2026', aims to amend Missouri's insurance laws concerning health benefit plans and organ transplants. The bill specifically prohibits health carriers or health benefit plans from covering human organ transplants or post-transplant care if these procedures occur in the People's Republic of China or if the organ is procured through sale or donation related to China. This legislation is framed within the context of ethical concerns surrounding organ acquisition practices in China, particularly regarding reports of coercion and lack of consent in organ harvesting.

Contention

Notably, the bill may stir debate regarding access to healthcare, particularly for those in need of organ transplants who may have connections to or interests in receiving care in China. Opponents of the bill may argue that it imposes unnecessary restrictions on patients seeking life-saving treatments and could limit their options unjustly. Furthermore, critics could raise concerns over the adequacy of domestic transplant programs and whether these restrictions aim to solve more significant universal healthcare issues or simply target specific practices without addressing root causes.